Latanoprost novum phenyl substitutum est propyl ester prostaglandin F2a, quod est receptaculum electionis selectivum F2a. Est substantia iners, quae cito penetrare in corneam potest. hydrolyzari potest in acida libera in cornea et plasmate activo. Potest augere fluxum humoris aquei per accumsan canthi. Dosis parva, sed potest promovere humoris aquei saturitatem. Liquor medicina potest penetrare in stratum superiorem choroideum ciliarem super oculum, et bonum effectum habet reducendi pressura intraocular.
Latanoprost ophthalmic solution is a medication administered into the eyes to control the progression of glaucoma or ocular hypertension by reducing intraocular pressure. It is a prostaglandin analogue (more specifically an analogue of prostaglandin F2α) that lowers the pressure by increasing the outflow of aqueous fluid from the eyes through the uvealsclearal tract. Latanoprost is an isopropyl ester prodrug, meaning it is inactive until it is hydrolyzed by esterases in the cornea to the biologically active acid.
